A detailed history of Mv Capital Management, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Mv Capital Management, Inc. holds 124 shares of CTLT stock, worth $7,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124
Previous 127 2.36%
Holding current value
$7,561
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$56.16 - $60.96 $168 - $182
-3 Reduced 2.36%
124 $7,000
Q2 2024

Aug 01, 2024

SELL
$53.58 - $57.02 $107 - $114
-2 Reduced 1.55%
127 $7,000
Q1 2024

Apr 18, 2024

BUY
$42.56 - $59.82 $255 - $358
6 Added 4.88%
129 $7,000
Q4 2023

Jan 29, 2024

SELL
$32.18 - $46.57 $3,571 - $5,169
-111 Reduced 47.44%
123 $5,000
Q3 2023

Nov 07, 2023

BUY
$44.2 - $50.2 $3,138 - $3,564
71 Added 43.56%
234 $10,000
Q2 2023

Aug 03, 2023

SELL
$31.86 - $67.26 $9,462 - $19,976
-297 Reduced 64.57%
163 $7,000
Q1 2023

Apr 26, 2023

BUY
$45.44 - $74.26 $4,498 - $7,351
99 Added 27.42%
460 $30,000
Q4 2022

Jan 27, 2023

BUY
$41.39 - $81.0 $8,567 - $16,767
207 Added 134.42%
361 $0
Q3 2022

Oct 24, 2022

BUY
$72.36 - $113.1 $7,597 - $11,875
105 Added 214.29%
154 $11,000
Q2 2022

Jul 19, 2022

BUY
$87.2 - $114.05 $3,052 - $3,991
35 Added 250.0%
49 $5,000
Q1 2022

May 09, 2022

SELL
$94.19 - $124.49 $6,875 - $9,087
-73 Reduced 83.91%
14 $2,000
Q4 2021

Feb 02, 2022

BUY
$119.57 - $139.07 $3,467 - $4,033
29 Added 50.0%
87 $11,000
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $2,183 - $2,847
20 Added 52.63%
58 $8,000
Q2 2021

Aug 03, 2021

BUY
$100.34 - $115.69 $3,210 - $3,702
32 Added 533.33%
38 $4,000
Q1 2021

May 12, 2021

BUY
$101.51 - $125.27 $609 - $751
6 New
6 $1,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.